Judie Barbara Alimonti (1960–2017) was a Canadian immunologist known for her research on the
RVSV-ZEBOVEbola vaccine.[1]
In 1991, Alimonti received a Bachelor of Science degree in microbiology from the
University of British Columbia. She later earned a PhD in immunology from the
University of Manitoba.[1] Alimonti managed the Canadian testing of a human-grade Ebola vaccine at the
National Microbiology Laboratory in Winnipeg, Manitoba.[2][3] When Ebola research at the lab began to founder, Alimonti set up a
Skunkworks project within the lab to continue the research.[4] Alimonti was employed as a contract scientist at the lab and left their employment in 2015.[5][1]
Alimonti died of cancer in December 2017 in Ottawa.[1]